Recombinant FIX Fc fusion protein activity assessment with the one‐stage clotting assay: A multicenter, assessor‐blinded, prospective study in Japan (J‐Field Study)

por Fukutake, Katsuyuki, Kobayashi, Tomomi, Sommer, Jurg M., Hirakata, Toshiyuki
Publicado 2019

Evaluation of recombinant factor VIII Fc (Eloctate) activity by thromboelastometry in a multicenter phase 3 clinical trial and correlation with bleeding phenotype

por Driessler, Frank, Miguelino, Maricel G., Pierce, Glenn F., Peters, Robert T., Sommer, Jurg M.
Publicado 2017

Real‐world assay variability between laboratories in monitoring of recombinant factor IX Fc fusion protein activity in plasma samples

por Sommer, Jurg M., Sadeghi‐Khomami, Ali, Barnowski, Christopher, Wikén, Margareta, Willemze, Annemieke J.
Publicado 2020

Recombinant Factor IX Fc Fusion Protein Maintains Full Procoagulant Properties and Exhibits Prolonged Efficacy in Hemophilia B Mice

por Toby, Garabet G., Liu, Tongyao, Buyue, Yang, Zhang, Xin, Bitonti, Alan J., Pierce, Glenn F., Sommer, Jurg M., Jiang, Haiyan, Peters, Robert T.
Publicado 2016

A Single Chain Variant of Factor VIII Fc Fusion Protein Retains Normal In Vivo Efficacy but Exhibits Altered In Vitro Activity

por Buyue, Yang, Liu, Tongyao, Kulman, John D., Toby, Garabet G., Kamphaus, George D., Patarroyo-White, Susannah, Lu, Qi, Reidy, Thomas J., Mei, Baisong, Jiang, Haiyan, Pierce, Glenn F., Sommer, Jurg M., Peters, Robert T.
Publicado 2014